Skye Bioscience, Inc. Common Stock (SKYE) — Cash Flow Reinvestment Rate
Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow Reinvestment Rate of 8.56x as of June 2014, reinvesting $67.83K (capex $67.83K ) from operating cash flow of $7.92K. See Skye Bioscience, Inc. Common Stock (SKYE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Skye Bioscience, Inc. Common Stock Cash Flow Reinvestment Rate (2012–2012)
Historical reinvestment intensity for Skye Bioscience, Inc. Common Stock across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Skye Bioscience, Inc. Common Stock.
Annual Cash Flow Reinvestment Rate for Skye Bioscience, Inc. Common Stock (2012–2012)
Year-by-year capital reinvestment analysis for Skye Bioscience, Inc. Common Stock. See SKYE free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2012 | 0.00x | $0.00 | $1.93K | $0.00 | — |